Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study.

Autor: Curcic J; Novartis Institutes for Biomedical Research, Basel, Switzerland., Vallejo V; Novartis Institutes for Biomedical Research, Basel, Switzerland., Sorinas J; Novartis Institutes for Biomedical Research, Basel, Switzerland., Sverdlov O; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States., Praestgaard J; Novartis Institutes for Biomedical Research, Cambridge, MA, United States., Piksa M; Novartis Institutes for Biomedical Research, Basel, Switzerland., Deurinck M; Novartis Institutes for Biomedical Research, Basel, Switzerland., Erdemli G; Novartis Institutes for Biomedical Research, Cambridge, MA, United States., Bügler M; Altoida Inc, Washington, DC, United States., Tarnanas I; Altoida Inc, Washington, DC, United States.; Global Brain Health Institute, Trinity College, Dublin, Ireland., Taptiklis N; Cambridge Cognition Ltd, Cambridge, United Kingdom., Cormack F; Cambridge Cognition Ltd, Cambridge, United Kingdom., Anker R; MindMaze SA, Lausanne, Switzerland., Massé F; MindMaze SA, Lausanne, Switzerland., Souillard-Mandar W; Linus Health, Boston, MA, United States.; Massachusetts Institute of Technology, Cambridge, MA, United States., Intrator N; Neurosteer Inc, New York, NY, United States., Molcho L; Neurosteer Inc, New York, NY, United States., Madero E; Neurotrack Technologies Inc, Redwood City, CA, United States., Bott N; Department of Medicine, School of Medicine, Stanford University, Stanford, CA, United States., Chambers M; Neurovision Imaging Inc, Sacramento, CA, United States., Tamory J; Neurovision Imaging Inc, Sacramento, CA, United States., Shulz M; ViewMind Inc, New York, NY, United States., Fernandez G; ViewMind Inc, New York, NY, United States., Simpson W; Winterlight Labs, Toronto, ON, Canada., Robin J; Winterlight Labs, Toronto, ON, Canada., Snædal JG; Memory Clinic, Landspitali, Reykjavik, Iceland., Cha JH; Novartis Institutes for Biomedical Research, Cambridge, MA, United States., Hannesdottir K; Novartis Institutes for Biomedical Research, Cambridge, MA, United States.

Publikováno v: JMIR research protocols [JMIR Res Protoc] 2022 Aug 10; Vol. 11 (8), pp. e35442. Date of Electronic Publication: 2022 Aug 10.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study.

Autor: Muurling M; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands. m.muurling@amsterdamumc.nl., de Boer C; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Kozak R; Takeda Pharmaceuticals International Co., Cambridge, MA, USA., Religa D; Department of Neurobiology, Care Sciences and Society, Karolinska Insitutet, Stockholm, Sweden., Koychev I; Department of Psychiatry, University of Oxford, Oxford, UK., Verheij H; Lygature, Utrecht, The Netherlands., Nies VJM; Lygature, Utrecht, The Netherlands., Duyndam A; Lygature, Utrecht, The Netherlands., Sood M; Fraunhofer Institute for Algorithms and Scientific Computing, University of Bonn, Bonn, Germany., Fröhlich H; Fraunhofer Institute for Algorithms and Scientific Computing, University of Bonn, Bonn, Germany., Hannesdottir K; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Erdemli G; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Lucivero F; Ethox and Welcome Centre for Ethics and Humanities, University of Oxford, Oxford, UK., Lancaster C; Big Data Institute, University of Oxford, Oxford, UK., Hinds C; Big Data Institute, University of Oxford, Oxford, UK., Stravopoulos TG; Information Technologies Institute, Center for Research and Technology Hellas (CERTH-ITI), Thessaloniki, Greece., Nikolopoulos S; Information Technologies Institute, Center for Research and Technology Hellas (CERTH-ITI), Thessaloniki, Greece., Kompatsiaris I; Information Technologies Institute, Center for Research and Technology Hellas (CERTH-ITI), Thessaloniki, Greece., Manyakov NV; Data Science and Clinical Insights, Janssen Research & Development, Beerse, Belgium., Owens AP; Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Narayan VA; Janssen Neuroscience Research & Development, Titusville, NJ, USA., Aarsland D; Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway., Visser PJ; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Publikováno v: Alzheimer's research & therapy [Alzheimers Res Ther] 2021 Apr 23; Vol. 13 (1), pp. 89. Date of Electronic Publication: 2021 Apr 23.

Response to "Use of Qualitative Data to Support Content Validity of Performance-Based Cognitive Outcome Assessments".

Autor: Ropacki MT; Strategic Global Research & Development, Half Moon Bay, CA, USA., Hannesdottir K; Novartis Institutes for Biomedical Research Inc, Cambridge, MA, USA., Hendrix S; Pentara Corporation, Salt Lake City, UT, USA., Gordon MF; TEVA Pharmaceuticals USA Inc, North Wales, PA, USA., Stephenson D; Coalition Against Major Diseases, Critical Path Institute, Tucson, AZ, USA., Coons SJ; Patient-Reported Outcome Consortium, Critical Path Institute, Tucson, AZ, USA., Stern RA; Alzheimer's Disease Center, Boston University School of Medicine, Boston, MA, USA.

Publikováno v: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2018 Jul; Vol. 52 (4), pp. 405-406.